Biocartis
Edit

Biocartis

https://www.biocartis.com/
Last activity: 13.03.2023
Tags:CareCommerceDiagnosticsHealthTechIndustryInformationPersonalPlatformTechnologyTime
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. The Company’s proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest and largest growing segments of the US$5 billion MDx market1 which is expected to grow to approximately US$8 billion in 2018.* Biocartis employs approximately 300 people and is headquartered in Mechelen, Belgium. Further information can be found at: www.biocartis.com * http://www.alliedmarketresearch.com/ivd-in-vitro-diagnostics-market
Likes
1209
Mentions
48
Location: Belgium, Antwerp, Mechelen
Employees: 501-1000
Total raised: $375.927645M
Founded date: 2007

Investors 6

Funding Rounds 6

DateSeriesAmountInvestorsDeal News
11.05.2021Grant$1.703581M-marketscre...
27.04.2015-$108.76043...-startuptic...
05.09.2014-$83.53905M-finsmes.co...
06.11.2013Series E$40.545252...-startuptic...
12.12.2012Series D$45.628764...-finsmes.co...
17.11.2011Series C$95.750563...-startuptic...

Mentions in press and media 48

DateTitleDescriptionSource
13.03.20236 questions for SMEs and start-ups looking to become more su...You can find the original interview (NL) in Trends magazine here. Sustainability is the corporate s...heranpartn...
16.11.2022Press release Biocartis Group NV: Biocartis launches a right...-globenewsw...
26.08.2022Global Liquid Biopsy Products Market Developing Sector Trend...Liquid Biopsy Products Market Liquid Biopsy Products Market Regional Standpoint: North America, Eur...einpresswi...
10.01.2022Press release Biocartis Group NV: BIOCARTIS MEETS 2021 KEY O...PRESS RELEASE: REGULATED INFORMATION 10 January 2022, 07:00 CET BIOCARTIS MEETS 2021 KEY OBJECTIVES...marketscre...
10.01.2022BIOCARTIS : MEETS 2021 KEY OBJECTIVESPRESS RELEASE REGULATED INFORMATION 10 January 2022, 07:00 CET BIOCARTIS MEETS 2021 KEY OBJECTIVE...marketscre...
10.11.2021Press release Biocartis Group NV: Biocartis Q3 2021 Business...PRESS RELEASE: REGULATED INFORMATION 10 November 2021, 07:00 CET BIOCARTIS Q3 2021 BUSINESS UPDATE ...marketscre...
02.11.2021Intervest realises fourth turnkey project for tenant Biocart...Biocartis, located in the Intercity Business Park Mechelen, expands its existing office of 717m² wit...marketscre...
12.10.2021Biocartis : Disclosure of a transparency notificationPRESS RELEASE REGULATED INFORMATION 12 October 2021, 07:00 CEST Disclosure of a transparency noti...marketscre...
23.09.2021Biocartis : Announces Restart of its High-Throughput Cartrid...PRESS RELEASE 23 September 2021, 07:00 CEST Biocartis Announces Restart of its High-Throughput Ca...marketscre...
13.09.2021Biocartis : Disclosure of a transparency notificationPRESS RELEASE REGULATED INFORMATION 13 September 2021, 17:40 CEST Disclosure of a transparency no...marketscre...
Show more